Government Affairs
Refine Search
Pharmaceutical
Now that US drugmakers Allergan and Pfizer have confirmed they are in acquisition talks (The Pharma Letter October 29), the focus turns to US politics and tax inversion-designed transactions, as analysts and investors express growing fears that the US government will try to block the deal. 16 November 2015
Generics
The Off-patent Drugs Bill was debated in the UK Parliament last week, having been proposed for a second reading by Nick Thomas-Symonds MP. 9 November 2015
Pharmaceutical
Trade group Farmaindustria and Spain’s Ministries of Finance and Public Administrations and of Health, Social Services and Equality last week signed a Protocol of Collaboration – aimed at guaranteeing the sustainability of the Spanish NHS (SNS) and access to innovation. 9 November 2015
Pharmaceutical
US Senators Susan Collins (Republican, Maine) and Claire McCaskill (Democrat, Missouri), who together lead the Senate Special Committee on Aging, today announced a bipartisan Senate investigation into the pricing of pharmaceutical products. 4 November 2015
Pharmaceutical
Producing drugs is an expensive business, and to help ensure the sustainability of such a business, drugmakers are granted patents that protect product innovations, writes Dr Nicola Davies in her monthly exclusive for The Pharma Letter. 26 October 2015
Pharmaceutical
Russia has no plans to introduce any bans and restrictions on the imports of drugs from abroad, according to recent statements of Russia’s President Vladimir Putin. 14 October 2015
Biosimilars
The USA’s Biosimilars Forum has expressed support for Senators Pat Roberts (Republican, Kansas) and Tom Carper (Democrat, Delaware) as well as 18 additional Senators for their leadership in sending a letter to Andrew Slavitt, Acting Administrator for the Centers for Medicare & Medicaid Services (CMS) regarding the provisions relating to biosimilar reimbursement in the CMS's 2016 Medicare Physician Fee Schedule proposed rule. 13 October 2015
Biotechnology
The USA and 11 other Pacific Rim nations on Monday agreed to the Trans-Pacific Partnership, the largest regional trade accord in history, a potentially precedent-setting model for global commerce and worker standards that would tie together 40% of the world’s economy. 5 October 2015
Pharmaceutical
Speaking at European Health Forum Gastein, which took place in Austria last week, European Commissioner for Health Vytenis Andriukaitis called for a new partnership between pharmaceutical companies and European Union member states to ensure access to medicines while securing the future of bio-pharmaceutical innovation. 4 October 2015
Biosimilars
The US Generic Pharmaceutical Association (GPhA) and its Biosimilars Council remain hopeful that discussions in Atlanta translate to Trans-Pacific Partnership (TPP) language that promotes access to treatments for patients all over the world. 3 October 2015
Pharmaceutical
A pressure group has called on the UK’s Health Secretary Jeremy Hunt to grant a compulsory license for patents that cover Kadcyla (trastuzumab emtansine) from Roche. 2 October 2015
Biotechnology
At the Trans-Pacific Partnership (TPP) negotiations in Atlanta, the US Trade Representative (USTR) is pushing the same harmful pharmaceutical proposal that many countries have rejected as recently as August – but wrapped in different packaging, according to US consumer advocacy Public Citizen. 1 October 2015
Biotechnology
EuropaBio, the trade association for the European biotech industry, has called on EU policymakers to continue promoting innovation while maintaining safety and efficacy standards. 30 September 2015
Pharmaceutical
French pharma representative body hits back at 'blatant inadequacy' of social security financing law
The French industry body representing pharma has spoken out against what it terms the “blatant inadequacy” of the draft French social security financing law and urges lawmakers to take into account the real challenges facing the healthcare system. 29 September 2015
Biotechnology
Trade group AusBiotech revealed today that it has made a submission to IP Australia’s consultation on improvements to the Innovation Patent system and the Advisory Council on Intellectual Property’s (ACIP) recommendation to abolish the system. 29 September 2015
Pharmaceutical
Last week, senior representatives of the pharmaceutical industry, including Richard Bergström, director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Imants Sinka and Dita-Erna Sile, respectively chairman and director general of the Latvian Association of International Research-based Pharmaceutical Manufacturers (SIFFA), met in Riga with Latvian Minister of Health Guntis Belēvičs. 28 September 2015
Pharmaceutical
The USA-based AIDS Healthcare Foundation (AHF) has denounced the lack of regulation and pharmaceutical industry greed that has led to record drug prices for specialty medications and billions of dollars in profits for drug manufacturers. 25 September 2015
Biotechnology
Hillary Clinton, the frontrunner Democratic presidential candidate in the USA, has said that, if elected, she would implement programs to force the pharmaceutical industry to concede tens of billions of dollars a year in tax breaks, lower prices and increase research spending. 23 September 2015
Biotechnology
India can emerge as a key provider of high-end analytics based on genomics big data, stated Vijay Raghavan, Secretary, Department of Biotechnology, Ministry of Science & Technology, Government of India, at an interactive session on biotechnology on day two of the ‘Indian Economic Convention.’ 21 September 2015
Pharmaceutical
An Australian Senate Committee inquiry has issued its findings and has recommended the government reviews the way in which new medicines are approved and subsidized. 18 September 2015
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze